The interplay between peripheral and central inflammation has a significant role in dopaminergic neural death in nigrostriatal pathway, although no direct assessment of inflammation has been performed in relation to dopaminergic neuronal loss in striatal nuclei. In this study, the correlation of neutrophil to lymphocyte ratio (NLR) as a marker of peripheral inflammation to striatal binding ratios 
Introduction
Progressive dopaminergic demise in the nigrostriatal system has long been considered the pathogenic mainstay of motor features in Parkinson's disease (PD). Lots of ergot mechanisms have been enumerated responsible for the neural loss in PD, of which inflammation, both central and peripheral has been explained in the initiation and progression of PD.
Inflammatory processes, which once were believed to be just the afterclap of neural death, are now considered as an etiological factor, which are also presented in early stages of PD. Several PD susceptibility genes are documented to be involved in the functions of immunity components like microglia (Liu et al., 2011; Pihlstrom et al., 2013; Russo et al., 2014) . The result from polymorphism studies determined several pro-inflammatory genes such as IL-1β ,TNF-α, HLA-DBQ1, HLA-DRA, and HLA-DRB1 to be associated with increased susceptibility to PD (Wahner et al., 2007; Ahmed et al., 2012) . It is also proved that nonsteroidal anti-inflammatory (NSAIDs) can in long term diminish the risk of PD (Rees et al., 2011) . In essence, authors exhibited that dopaminergic neurons are selectively susceptible to oxidative stress and inflammation (Pott Godoy et al., 2008; Liu and Bing, 2011) . Freshly, a neuroimaging study using positron emission tomography (PET), detected activated microglia in the SN and putamen of one-year duration PD patients (Iannaccone et al., 2013) , implying that there is an active inflammatory condition in initial phases of PD. Furthermore, authors suggested that inflammatory circumstances, both central and peripheral, are present in the prodromal PD (Su and Federoff, 2014; Dzamko et al., 2015) . Altogether, these immense lines of evidence highly signify the importance of inflammation in the pathophysiology of PD.
A robust body of evidence has espoused the involvement of peripheral inflammatory conditions in the pathophysiology of PD. In this context, markers of peripheral inflammatory processes including, but not limited to, TNF-α and its receptors and IL-1β have been exhibited to be elevated in in individuals with PD in the peripheral blood (Dobbs et al., 1999; Katsarou et al., 2007; Scalzo et al., 2009; Koziorowski et al., 2012; Rocha et al., 2014) , cerebrospinal fluid and post-mortem brain tissues (Mogi et al., 1994; Dobbs et al., 1999; Reale et al., 2009a; Reale et al., 2009b) . Related data showed IL-6 is associated with increased risk of development of PD (Scalzo et al., 2010) . Besides the peripheral immune markers, peripheral immune cells undergo some quantitative alternations in PD patients. The most prominent of these changes is the lower total number of lymphocytes in individuals with PD compared to controls mainly due to decrement in percentage of CD3+ and CD19+ lymphocytes (Bas et al., 2001; Baba et al., 2005; Saunders et al., 2012; Stevens et al., 2012) . Furthermore, decreased counts of T helper cells and increased/unchanged counts of cytotoxic T cells have been documented in PD patients (Calopa et al., 2010) .
Owing to the presence of blood-brain-barrier (BBB), central nervous system (CNS) is an immuneprivileged organ. However, BBB dysfunction have been postulated to play a key role in the pathogenesis of neurodegenerative diseases like PD (Kortekaas et al., 2005; Hirsch and Hunot, 2009) .
It has been shown that endothelium residing in SNpc of patients with PD, undergoes radical pathologic morphological changes (Faucheux et al., 1999; Guan et al., 2013) , and CD4+ and CD8+ Tlymphocytes have been reported to enter and invade the SNpc of idiopathic PD patients (Phani et al., 2012) . Using a mouse model involving injection of vascular endothelial growth factor (VEGF) (a detrimental protein to BBB) into the mice SNpc, researchers demonstrated a significant association between BBB dysfunction and dopaminergic cell death (Rite et al., 2007; Yasuda et al., 2007) . , Furthermore, inflammatory cytokines can induce the activation of microglia and therefore the dopaminergic cell death. In this context, one of the valid indicators for peripheral inflammatory processes is the neutrophil to lymphocyte ratio (NLR) (Alkhouri et al., 2012) representing the active inflammation (neutrophils) merged with immunological regulatory processes (lymphocytes).
Despite lots of evidence on the role of inflammation in dopaminergic neural loss, no direct assessment has been performed in this regard. This work was designed to investigate peripheral inflammation in terms of NLR concerning loss of dopaminergic uptake in caudate and putamen on Dopamine Transporter Single Photon Emission Computed Tomography (DaTscan) images, which signifies the dopaminergic activity, among treatment-naïve early PD patients with different motor phenotypes and severities.
Methods

Participants
PD patients and healthy control (HC) subjects enrolled in this study were recruited from the Parkinson institutional review board of all participating sites. Written informed consent was obtained from all participants before study enrolment. The study was performed in accordance with relevant guidelines and regulations. Only baseline visit data are analyzed in this research. PD status was confirmed by Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and dopamine transporter deficit was observed on DAT scans. All PD patients at baseline were drug naïve, nondemented, on Hoehn and Yahr (H&Y) staging I or II, and were confirmed negative for any medical or psychiatric disorders apart from PD.
Clinical assessment and motor classification
Motor and non-motor symptoms were evaluated among subjects with clinical tests at baseline visits at each participating site. The most common PD rating scales, i.e., UPDRS, H&Y staging, and the Schwab and England rating of activities of daily living (Modified Schwab & England ADL) were assessed (Perlmutter, 2009) . Tremor score and postural instability and gait difficulty (PIGD) score were identified for PD subjects with MDS-UPDRS. Then PD subjects were classified into 3 groups of tremor dominant (TD), PIGD and intermediate based on the ratio of tremor score/PIGD score. If ratio >= 1.15 or PIGD=0 and tremor>0, then the subject was TD. If ratio <= 0.9, the subject was classified as PIGD. If ratio > 0.9 and < 1.15, or tremor score and PIGD score = 0, the subject was tagged as indeterminate (Stebbins et al., 2013) . Non-motor symptoms were investigated by the Montreal Clinic Assessment (MoCA) for mild cognitive impairment, 15-item geriatric depression scale (GDS) for depressive symptoms, The University of Pennsylvania Smell Identification Test (UPSIT) for olfaction function, and independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT) for autonomic dysfunction.
Blood sample collection
collection was completed at each study site. PAXgene blood RNA tubes were utilized for the collection of blood samples following the study protocol. The number of neutrophils and lymphocytes were calculated by autoanalyzer device on participants' whole blood samples, right after the collection. NLR was simply calculated by dividing neutrophil to lymphocyte count.
Dopaminergic imaging
As a preventive measure, all females with the potential of pregnancy were confirmed negative for urine pregnancy test prior to receiving the 123 Ioflupane single-photon emission computed tomography (SPECT) injection. None of the subjects had received any of the drugs that would interfere with DAT SPECT imaging within 6 months of screening (full PPMI study protocol is provided visit from all participating cites were centrally reconstructed and were attenuation corrected, followed by spatial normalization for consistent orientation by experienced nuclear medicine experts. Standard volume of interest template was applied on caudate, putamen and occipital regions. Striatal Binding Ratios (SBR) for left and right putamen and caudate were finally calculated, using the formula: (SBR) = (striatal region)/(occipital) -1, where occipital lobe DAT count is the reference (Seibyl et al., 2013) .
Regarding motor dominancy, SBRs of ipsilateral and contralateral putamen and caudate were compared between PD and HC and within PD motor subtypes. The calculated average of SBRs for the left and the right nuclei is presented for healthy controls or symmetrical motor involvement in PD individuals.
Statistical analysis
The statistical analysis was performed using SPSS version 22 (BM Corp., Armonk, NY, USA).
Pearson's chi-square was used to assess nominal variables across groups. Mann-Whitney U test was used to assess differences between healthy controls and PD patients, and Kruskal-Wallis test was used for multiple comparisons in three groups of PD motor subtypes. Spearman's rank-order correlation was used to test the association between NLR and other characteristics in patients with Parkinson's disease. Finally, P values less than 0.05 were considered to be statistically significant.
Results
Between group comparisons
NLR and DAT scan data were provided for 388 de-novo PD patients and 148 HC on baseline visits.
Baseline clinical characteristics and detailed demographic data of PD and HC subjects are demonstrated in table 1. Healthy participants were age and sex matched to PD patients, while scored higher on all motor and non-motor tests. As expected, PD patients had significantly lower SBRs in striatal nuclei. NLR was significantly higher in PD cohort.
As shown in table 2, there was no difference between age, gender, UPDRS-III as well as NLR and SBRs in both ipsilateral and contralateral striatal nuclei among PD motor subtypes.
Correlations between NLR and other clinical and imaging metrics
Spearman's rank-order correlation was performed in healthy controls and three subgroups of PD patients (Table 3) 
Discussion
In search of possible correlation between peripheral inflammation and striatal DAT availability in a large sample of drug-naïve early PD patients, we found that (1) NLR is significantly higher in PD patients than age and sex matched healthy controls. (2) Although NLR and striatal SBR did not differ between subtypes of PD in the early stages of the disease, only TD phenotype and more specifically at H&Y stage II confirmed predictive value of NLR to dopaminergic loss in bilateral striatal nuclei. (3) Worse motor severity was associated with higher NLR values in only TD phenotype.
Tremor is a cardinal motor feature of PD that has always exhibited unalike clinical course to other motor phenotypes. In contrast to TD, non-tremor dominant subtypes, especially PIGD predict worse and rapid disease progression with higher rates of non-motor features such as cognitive decline, mood disturbances, REM sleep behavior disorder and olfaction dysfunction (Jankovic and Kapadia, 2001; Burn et al., 2006; Kumru et al., 2007; Reijnders et al., 2009; Iijima et al., 2011; Konno et al., 2018) . A longitudinal study has revealed that TD patients will not develop dementia until irreversibly convert to PIGD phenotype (Alves et al., 2006) . Differed clinical pattern is also reflected on structural and functional assays. Autopsy of TD-PD patients has exposed less severe dopaminergic loss in SN than other PD subtypes (Paulus and Jellinger, 1991; Selikhova et al., 2013) . This is in concordance with slower progression of symptoms in this group (Jankovic and Kapadia, 2001; Rajput et al., 2009) , and is replicated on a recent probabilistic tractography study, which has revealed normal structural connectivity in nigro-pallidal and fronto-striatal circuits in TD patients, which was altered in non-TD (Barbagallo et al., 2017) . Postmortem studies have also demonstrated distinct striatal pathology among different PD motor subtypes. While akinesia and rigidity evolve from cell loss in ventrolateral SNpc which project to the posterior putamen, degeneration in TD is most prominent in dorsomedial SNpc projecting to the caudate and anterior putamen, and to the retrorubral field with subsequent projections to the dorsolateral striatum and ventromedial thalamus (Jellinger, 1999 (Eggers et al., 2011) . This pattern is consistent with our finding of NLR correlation to lower dopamine uptake in both putamen and caudate in TD subgroup, while it was linked to lower DAT binding in putamen and not caudate in all PD patients. In fact, there is consistent report of higher extent of dopamine depletion in putamen than caudate in PD (Pikstra et al., 2016) .
Moreover, it is proposed that tremor severity may have a different mechanism than other motor features, as in contrast to bradykinesia and rigidity does not depend on the degree of reduced striatal dopamine uptake (Otsuka et al., 1996; Rossi et al., 2010; Eggers et al., 2012; Pikstra et al., 2016) , but rather on relative contribution of reduced dopamine in putamen and caudate, indicative of more severe caudate involvement (Otsuka et al., 1996) . Therefore, strong correlation of NLR to SBR in caudate of TD patients, but weak association with putamen agrees with these sightings. In this study, we did not find any difference between SBR values in ipsilateral or contralateral caudate and putamen nuclei between three examined subtypes with similar motor stage and severity. However, early drug-naïve TD patients of another study have shown higher DAT availability on bilateral putamen but no difference on caudate nuclei compared to akinetic-rigid PD patients with higher UPDRS-III and H&Y (Moccia et al., 2014) . This may point to the possibly greater impact of putamen on motor severity in non-TD phenotype. In this study we did not investigate other neurotransmitters than dopamine which are conferred regarding tremorgenesis and its severity is shown to be mediated by reductions of serotonin transporter availability in the raphe nuclei more than that of dopamine in putamen (Qamhawi et al., 2015; Pasquini et al., 2018) , or mediated by neurotransmitter imbalance between reduced GABAergic inhibitory influx from putamen confronted to intact dopaminergic input from SN to the internal pallidum (Rajput et al., 2008) .
On the other hand, we found surprisingly, much more substantial reduction in DAT availability in ipsilateral putamen and caudate and a weak reduction in contralateral nuclei in TD patients at H&Y
stage II compared to TD at stage I. This is also true for the strong correlation of NLR to ipsilateral caudate (p value= 0.003) and a weak relationship with contralateral caudate nucleus (p value= 0.04).
Motor symptoms in PD are considered to evolve from dopaminergic depletion in contralateral nigrostriatal system. However, there are several recent reports of motor dominancy ipsilateral to the side of predominant dopaminergic deficit, especially in TD patients (Aguirregomozcorta et al., 2013; Erro et al., 2013; Hoshiyama et al., 2015) . This is also true for medication naïve TD patients from PPMI cohort on early stages of the disease (Kaasinen, 2016) . Another study on PPMI cohort (Pasquini et al., 2018) disclosed that a proportion of TD group at baseline progressed to bilateral limb involvement over 2 years follow up, which may be due to the observed ipsilateral striatal dopamine depletion in this study. et al., 2017) . The later study also did not find any difference between TD and akinetic-rigid subtypes. These studies have assessed relatively small sample sizes of PD patients already on dopaminergic replacement therapy, which is shown to recover changes on T-lymphocytes (Kustrimovic et al., 2016) . In this study we surveyed larger sample of 388 drug-naïve PD patients who showed higher levels of NLR (2.5 ± 0.9) compared to 148 age-matched healthy controls (NLR= 2.2 ± 0.8), although there was no such difference within PD subtypes. NLR is also shown to be attributed to lower connectivity in several white matter tracts implicated in early or prodromal PD pathology (Haghshomar et al., 2017) .
Several studies have manifested that PD progression does not follow a linear model and decline in striatal uptake observed on DATscans are more rapid in early stages of the disease followed by a much more slower progression in advanced stages (Fearnley and Lees, 1991; Jennings et al., 2001; Nurmi et al., 2001 ). Therefore, it seems that early stages of the disease without the interference of dopaminergic replacement therapy, is the best point during the disease course to evaluate the contribution of inflammation to dopaminergic loss. A growing body of evidence suggests that presynaptic terminals in dorsal striatum undergo degeneration even prior to the SN and axonal degeneration should be the primary target for neuroprotective therapies (Tagliaferro and Burke, 2016) . This is supported by in vivo DAT SPECT (Caminiti et al., 2017) and confirms that lower SBRs in putamen and caudate nuclei truly reflect the nigrostriatal pathology in early stages of PD. However, study on early stages impose some limitations that should be considered when interpreting our results.
First, motor classification tends to change during the course of the disease, and our subtype classification was only based on screening visits. Second, tremor predominant PD patients recognize the symptoms and seek medical advice earlier and owing to the more benign course more readily cooperate with PPMI project that includes patients not receiving any parkinsonian treatment for 6 months. Therefore, higher number of cases tagged in TD subgroup and relatively fewer cases in PIGD and intermediate in PPMI cohort may have contributed to the false negative results in non-tremor predominant groups. More studies are clearly needed to investigate the generatability of these solid findings.
Conclusion
In this research we investigated the association between immune and nervous system. PD patients were divided into three groups based on tremor/PIGD score, being TD, PIGD, and intermediate subgroups.
We demonstrated that NLR can negatively predict SBR in bilateral putamen and caudate nuclei of TD group, and more specifically in stage 2 (H&Y) TD patients. Not observing such association in non-tremor predominant PD patients points to the different pathophysiology mechanisms between tremor and other motor symptoms in PD. Making a bridge between inflammation and neurodegeneration, it is suggested that peripheral inflammation can potentially contribute to the initiation and progression of PD, particularly the process of dopaminergic depletion in striatal regions. However, this relation between peripheral inflammation and parkinson progression is not conclusive. Much more studies are required to further investigate this subject.
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